article thumbnail

Precision Medicine Could Have a Major Impact on Healthcare Outcomes and Costs - SPONSOR CONTENT FROM SIEMENS HEALTHINEERS

Harvard Business Review

The transformation of health care continues at a rapid pace, bringing opportunities and challenges for health care providers to deliver improved clinical outcomes at lower costs. And many health care systems continue to struggle to reliably deliver evidence-based care.

Cost 8
article thumbnail

Should Big Companies Give Up on Innovation?

Harvard Business Review

It’s a common question thrown at me by entrepreneurs, venture capitalists, or the more cynically minded corporate leaders. Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. No 20,000 tech jobs. I know many smart investors didn't.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. No 20,000 tech jobs. I know many smart investors didn't.

article thumbnail

Artificial Intelligence Is Almost Ready for Business

Harvard Business Review

AI is filling this gap as it becomes ingrained in the analytics technology infrastructure in industries like health care, financial services, and travel. Rather than take the cutting edge capabilities developed in its research labs to market as a series of products, IBM has chosen to offer a platform of services under the Watson brand.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

With its Emerging Businesses (EB) group (where one of us serves as President), Merck started a journey about three years ago with a core investment thesis: there are areas of growing unmet need in health care that intersect with its established competencies.

article thumbnail

The 5 Things IBM Needs to Do to Win at AI

Harvard Business Review

The kinds of shifts we’re talking about have come more naturally to greatly successful startups of the last two decades — Google, Amazon, Uber, and Facebook among them — and their venture capital investors. Develop a portfolio of capabilities with different risk/return profiles. assets of the Weather Channel).